StockData
uniQure N.V. logo

uniQure N.V. (QURE) stock

QURENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30217% above fair value
$20.23−0.07 (-0.34%)

Close on Nov 19, 2026Market cap $1.40BP/E –Yield –

uniQure operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

uniQure's operating income for the twelve months ending Jun 30, 2026 was -$200.08M. For fiscal 2025 it was -$185.35M. The highest annual figure on record is $310.62M in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$185.35M–
FY2024Dec 31, 2024-$184.29M–
FY2023Dec 31, 2023-$282.87M–
FY2022Dec 31, 2022-$143.16M-146.1%
FY2021Dec 31, 2021$310.62M–
FY2020Dec 31, 2020-$125.43M–
FY2019Dec 31, 2019-$121.14M–
FY2018Dec 31, 2018-$88.23M–
FY2017Dec 31, 2017-$71.34M–
FY2016Dec 31, 2016-$71.95M–
FY2015Dec 31, 2015-$71.15M–
FY2014Dec 31, 2014-$53.68M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$52.20M–
Q1 FY2026Mar 31, 2026-$45.72M–
Q4 FY2025Dec 31, 2025-$51.12M–
Q3 FY2025Sep 30, 2025-$51.04M–
Q2 FY2025Jun 30, 2025-$43.87M–
Q1 FY2025Mar 31, 2025-$39.33M–
Q4 FY2024Dec 31, 2024-$45.83M–
Q3 FY2024Sep 30, 2024-$40.23M–
Q2 FY2024Jun 30, 2024-$44.01M–
Q1 FY2024Mar 31, 2024-$54.23M–
Q4 FY2023Dec 31, 2023-$61.75M-333.0%
Q3 FY2023Sep 30, 2023-$81.88M–
Q2 FY2023Jun 30, 2023-$65.07M–
Q1 FY2023Mar 31, 2023-$74.17M–
Q4 FY2022Dec 31, 2022$26.50M+1181.5%
Q3 FY2022Sep 30, 2022-$59.52M–
Q2 FY2022Jun 30, 2022-$56.06M-114.1%
Q1 FY2022Mar 31, 2022-$54.08M–
Q4 FY2021Dec 31, 2021$2.07M–
Q3 FY2021Sep 30, 2021-$45.00M–
Q2 FY2021Jun 30, 2021$398.01M–
Q1 FY2021Mar 31, 2021-$44.46M–
Q4 FY2020Dec 31, 2020-$8.27M–
Q3 FY2020Sep 30, 2020-$44.49M–
Q2 FY2020Jun 30, 2020-$38.21M–
Q1 FY2020Mar 31, 2020-$34.46M–
Q4 FY2019Dec 31, 2019-$32.98M–
Q3 FY2019Sep 30, 2019-$31.33M–
Q2 FY2019Jun 30, 2019-$29.33M–
Q1 FY2019Mar 31, 2019-$27.50M–
Q4 FY2018Dec 31, 2018-$24.21M–
Q3 FY2018Sep 30, 2018-$23.22M–
Q2 FY2018Jun 30, 2018-$21.20M–
Q1 FY2018Mar 31, 2018-$19.60M–
Q4 FY2017Dec 31, 2017-$22.65M–
Q3 FY2017Sep 30, 2017-$9.28M–
Q2 FY2017Jun 30, 2017-$19.71M–
Q1 FY2017Mar 31, 2017-$19.72M–
Q4 FY2016Dec 31, 2016-$16.39M–
Q3 FY2016Sep 30, 2016-$14.16M–

More uniQure figures

See a number that looks wrong?